𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Patient motivation and informed consent in a phase I study of an anticancer agent

✍ Scribed by Rodenhuis, Sjoerd; Van Den Heuvel, Wim J.A.; Annyas, Albert A.; Schraffordt Koops, Heimen; Sleijfer, Dirk Th.; Mulder, Nanno H.

Book ID
123599962
Publisher
Elsevier Science
Year
1984
Weight
615 KB
Volume
20
Category
Article
ISSN
0277-5379

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

KP1019, A New Redox-Active Anticancer Ag
KP1019, A New Redox-Active Anticancer Agent – Preclinical Development and Results of a Clinical Phase I Study in Tumor Patients
✍ Christianβ€…G. Hartinger; Michaelβ€…A. Jakupec; Stefanie Zorbas-Seifried; Michael Gr πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 347 KB πŸ‘ 1 views

## Abstract The promising drug candidate indazolium __trans__‐[tetrachlorobis(1__H__‐indazole)ruthenate(III)] (KP1019) is the second Ru‐based anticancer agent to enter clinical trials. In this review, which is an update of a paper from 2006 (__Hartinger etβ€…al., J. Inorg. Biochem.__ **2006**, __100_

ChemInform Abstract: KP1019, A New Redox
ChemInform Abstract: KP1019, A New Redox-Active Anticancer Agent β€” Preclinical Development and Results of a Clinical Phase I Study in Tumor Patients
✍ Christian G. Hartinger; Michael A. Jakupec; Stefanie Zorbas-Seifried; Michael Gr πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons βš– 16 KB πŸ‘ 1 views

## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a β€œFull Text” option. The original article is trackable v